Jason D. Speake - Concepedia

Author

Jason D. Speake

GlaxoSmithKline (United States)

Also Known As

J. D. SPEAKE, Jason D Speake, Jason D. Speake, Jason Speake

Publications

618

Citations

H-Index

Concepts

All Affiliations

GlaxoSmithKline (United States)Research Triangle Park Foundation Indiana University Bloomington Montana State University

About

Jason D. Speake is an author at GlaxoSmithKline (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	12	264
2	Biochemistry	7	7	134
3	Natural Sciences	3	3	72
4	Health Sciences	2	2	77
5	Cell Biology	1	1	17

Jason D. Speake

Publications

543

Citations

H-Index

Page 1

	Year	Citations
3D Molecular Descriptors Important for Clinical Success David C. Kombo, Kartik Tallapragada, Rachit Jain, Journal of Chemical Information and Modeling	2012	122
DNDI-6148: A Novel Benzoxaborole Preclinical Candidate for the Treatment of Visceral Leishmaniasis Charles E. Mowbray, Stéphanie Braillard, Paul A. Glossop, Journal of Medicinal Chemistry	2021	64
Systemic Administration of an Alpha-7 Nicotinic Acetylcholine Agonist Reverses Neuropathic Pain in Male Sprague Dawley Rats Lisa C. Loram, Frederick R. Taylor, Keith A. Strand, Journal of Pain Pain TherapyHealth SciencesPain MedicineMedicineNeuropathic Pain	2012	55
Regulation of Ingestive Behaviors in the Rat by GSK1521498, a Novel μ-Opioid Receptor-Selective Inverse Agonist Diane M. Ignar, Aaron S. Goetz, Kimberly Nichols Noble, Journal of Pharmacology and Experimental Therapeutics	2011	43
Discovery of 3-(5-Chloro-2-furoyl)-3,7-diazabicyclo[3.3.0]octane (TC-6683, AZD1446), a Novel Highly Selective α4β2 Nicotinic Acetylcholine Receptor Agonist for the Treatment of Cognitive Disorders Anatoly Mazurov, Lan Miao, Balwinder S. Bhatti, Journal of Medicinal Chemistry Psychotropic MedicationPeptide SciencePharmacotherapyCognitive DisordersPharmaceutical Chemistry	2012	33
Studies directed toward the total synthesis of scytophycin C: Synthesis of the C(1)C(18) fragment of scytophycin C Paul A. Grieco, Jason D. Speake Tetrahedron Letters	1998	28
Novel benzimidazole-based MCH R1 antagonists Andrew J. Carpenter, Kamal Albarazanji, Kevin K. Barvian, Bioorganic & Medicinal Chemistry Letters MedicineRational Drug DesignPharmacological AgentPharmacotherapyPharmacology	2006	26
2-(Anilinomethyl)imidazolines as α<sub>1</sub> Adrenergic Receptor Agonists: the Discovery of α<sub>1</sub><sub>a</sub> Subtype Selective 2‘-Alkylsulfonyl-Substituted Analogues Stephen J. Hodson, Michael J. Bishop, Jason D. Speake, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistrySulfide AnaloguesBiochemistrySulfone Oxidation State	2002	25
Analgesic effects mediated by neuronal nicotinic acetylcholine receptor agonists: Correlation with desensitization of α4β2* receptors Yun-De Xiao, Kristen G. Jordan, Philip S. Hammond, European Journal of Pharmaceutical Sciences Molecular PharmacologyHealth SciencesPain MedicineSynaptic TransmissionPhysiology	2012	22
α1-Adrenoceptor Agonists: The Identification of Novel α1A Subtype Selective 2′-Heteroaryl-2-(phenoxymethyl)imidazolines Michael J. Bishop, Kevin A Barvian, Judd Berman, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyBiochemistryMedicineMechanism Of ActionReceptor (Biochemistry)	2002	19

Page 1